Previous view was $460M-$480M. Ginkgo expects to add 55-60 new Cell Programs to the Foundry platform in 2022. Ginkgo further revised its expectation for Total revenue from $425 – $440 million to $460 – $480 million in 2022. While Biosecurity remains an uncertain business, based on strong year-to-date performance Ginkgo now expects Biosecurity revenue in 2022 of at least $310 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DNA: